Datavault AI Inc. (NASDAQ: DVLT) announced an expansion of its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS), extending the use of its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The amended agreement aims to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments. This move leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the revised terms, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
The expansion is significant because it moves Datavault AI’s technology into a broader healthcare ecosystem, addressing the growing demand for patient-centric data management. By integrating blockchain and AI, the partnership aims to give patients control over their health data, potentially allowing them to monetize their information securely. This could transform how healthcare data is handled, shifting from institution-controlled repositories to patient-owned assets. The focus on real-world asset tokenization also opens up new possibilities for investment and liquidity in healthcare assets.
Datavault AI, headquartered in Philadelphia, PA, is known for its AI-driven data experiences and asset monetization in the Web 3.0 environment. The company’s cloud-based platform offers solutions through its Acoustic Sciences and Data Sciences divisions. The Acoustic Sciences division features WiSA, ADIO, and Sumerian patented technologies for spatial and multichannel wireless audio, while the Data Science division leverages Web 3.0 and high-performance computing for data perception, valuation, and secure monetization. The company’s Information Data Exchange enables Digital Twins and licensing of name, image, and likeness by attaching physical objects to immutable metadata.
The expanded agreement is expected to have implications for the healthcare industry by introducing new models for patient data control and monetization. As the global health and wellness market continues to grow, Datavault AI’s technology could become a key enabler for decentralized health data ecosystems. For more information, visit the company’s newsroom at https://ibn.fm/DVLT and the full press release at https://ibn.fm/vBAxH.
